全文获取类型
收费全文 | 54151篇 |
免费 | 5546篇 |
国内免费 | 3741篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 1584篇 |
妇产科学 | 179篇 |
基础医学 | 3973篇 |
口腔科学 | 162篇 |
临床医学 | 4617篇 |
内科学 | 17052篇 |
皮肤病学 | 143篇 |
神经病学 | 316篇 |
特种医学 | 2276篇 |
外国民族医学 | 15篇 |
外科学 | 7366篇 |
综合类 | 10123篇 |
现状与发展 | 20篇 |
预防医学 | 2281篇 |
眼科学 | 34篇 |
药学 | 5603篇 |
29篇 | |
中国医学 | 4342篇 |
肿瘤学 | 3301篇 |
出版年
2024年 | 192篇 |
2023年 | 1149篇 |
2022年 | 1950篇 |
2021年 | 2422篇 |
2020年 | 2432篇 |
2019年 | 2024篇 |
2018年 | 1966篇 |
2017年 | 2248篇 |
2016年 | 2676篇 |
2015年 | 2395篇 |
2014年 | 3715篇 |
2013年 | 3634篇 |
2012年 | 3156篇 |
2011年 | 3575篇 |
2010年 | 2740篇 |
2009年 | 2647篇 |
2008年 | 2643篇 |
2007年 | 2666篇 |
2006年 | 2633篇 |
2005年 | 2174篇 |
2004年 | 1719篇 |
2003年 | 1501篇 |
2002年 | 1335篇 |
2001年 | 1236篇 |
2000年 | 1027篇 |
1999年 | 842篇 |
1998年 | 813篇 |
1997年 | 702篇 |
1996年 | 646篇 |
1995年 | 545篇 |
1994年 | 524篇 |
1993年 | 425篇 |
1992年 | 399篇 |
1991年 | 328篇 |
1990年 | 300篇 |
1989年 | 250篇 |
1988年 | 229篇 |
1987年 | 185篇 |
1986年 | 162篇 |
1985年 | 184篇 |
1984年 | 161篇 |
1983年 | 104篇 |
1982年 | 130篇 |
1981年 | 107篇 |
1980年 | 96篇 |
1979年 | 85篇 |
1978年 | 82篇 |
1977年 | 67篇 |
1976年 | 84篇 |
1975年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
2.
3.
目的了解何首乌致药物性肝损伤(Polygonum multiflorum-associated drug induce liver injury,PM-DILI)的临床病理学特点。方法收集2019年3月1日至2021年3月1日深圳市第三人民医院收治的8例PM-DILI患者临床资料。肝穿组织进行苏木素-伊红染色、网状纤维染色、Masson三色染色、铁、铜特殊染色和免疫组织化学染色,显微镜下观察分析。结果8例PM-DILI患者男女比为1∶1,平均年龄43岁,其中6例为急性PM-DILI,2例慢性为PM-DILI。入院血清学检查异常主要包括转氨酶升高和淤胆均为7例。主要组织病理学改变为点灶状坏死8例、界面炎5例、融合坏死4例,融合坏死以肝腺泡3带为主,不伴或伴少数炎细胞浸润;胆汁淤积5例,为肝腺泡3带的肝细胞、毛细胆管内淤胆,不伴或伴少数炎细胞浸润;中央静脉炎3例;病程长者可发生肝纤维化,甚至肝硬化2例。结论肝腺泡3带为主的急性淤胆和肝细胞坏死是PM-DILI主要组织学表现,严重者可发生静脉炎等血管损伤。 相似文献
4.
5.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
6.
7.
8.
B Maybury A Powell-Chandler N Kumar 《Annals of the Royal College of Surgeons of England》2015,97(3):e37-e38
We report two British cases of liver abscess, due to Klebsiella pneumoniae and associated with synchronous infection elsewhere, which required liver resection for definitive treatment. They illustrate the geographic spread of aggressive K pneumoniae liver infection and demonstrate the importance of early aggressive treatment. 相似文献
9.
10.